Zobrazeno 1 - 10
of 39
pro vyhledávání: '"J. P. COSTANTINO"'
Publikováno v:
Journal of the National Cancer Institute. 94(19)
Autor:
J P, Costantino
Publikováno v:
Annals of the New York Academy of Sciences. 949
Benefit/risk assessment (B/rA) can be used in a variety of circumstances encompassing clinical practice and research settings. Subsequent to the reporting of the results from the Breast Cancer Prevention Trial (BCPT), methodology was developed to per
Publikováno v:
Journal of the National Cancer Institute. 93(1)
The overall effect of prophylactic tamoxifen in women depends on the balance between the effects of the drug, which include preventing breast cancer and altering cardiovascular risk. In a recent clinical trial, postmenopausal estrogen-progestin thera
Autor:
Richard O. Day, D. Lawrence Wickerham, Patricia A. Ganz, J. P. Costantino, Bernard Fisher, Walter M. Cronin
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 17(9)
PURPOSE: This is the initial report from the health-related quality of life (HRQL) component of the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial. This report provides an overview of HRQL findings, comparing tamox
Publikováno v:
American journal of industrial medicine. 36(1)
We present the mortality experience for a cohort of women (n = 2,877) from a large epidemiologic study of production and fabrication high nickel alloys workers (n = 31,165). All the plants were located within the United States and cohort eligibility
Autor:
M B, Gorin, R, Day, J P, Costantino, B, Fisher, C K, Redmond, L, Wickerham, J E, Gomolin, R G, Margolese, M K, Mathen, D M, Bowman, D I, Kaufman, N V, Dimitrov, L J, Singerman, R, Bornstein, N, Wolmark, D, Kaufmann
Publikováno v:
American journal of ophthalmology, vol 125, iss 4
Gorin, MB; Day, R; Costantino, JP; Fisher, B; Redmond, CK; Wickerham, L; et al.(1998). Long-term tamoxifen citrate use and potential ocular toxicity. American Journal of Ophthalmology, 125(4), 493-501. doi: 10.1016/S0002-9394(99)80190-1. UCLA: Retrieved from: http://www.escholarship.org/uc/item/07q413qf
Gorin, MB; Day, R; Costantino, JP; Fisher, B; Redmond, CK; Wickerham, L; et al.(1998). Long-term tamoxifen citrate use and potential ocular toxicity. American Journal of Ophthalmology, 125(4), 493-501. doi: 10.1016/S0002-9394(99)80190-1. UCLA: Retrieved from: http://www.escholarship.org/uc/item/07q413qf
Purpose To estimate the prevalence of abnormalities in visual function and ocular structures associated with the long-term use of tamoxifen citrate. Methods A single-masked, cross-sectional study involving multiple community and institutional ophthal
Publikováno v:
Cancer. 80(1)
A disparity in breast carcinoma survival between African-American and white women has been noted over the past several decades. A major factor implicated in this disparity is stage of disease at diagnosis. In this study, survival and related endpoint
Publikováno v:
Ultrasound in obstetricsgynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology. 8(5)
The objective of this study was to determine whether vibroacoustic stimulation would improve the visualization rate of the four-chamber cardiac view. Patients between 26 and 42 weeks' gestation were considered to be candidates for this study if the a
Autor:
Eleftherios P. Mamounas, Nikolay V. Dimitrov, Sutherland C, David M. Bowman, Norman Wolmark, A G Glass, J. P. Costantino, James J. Dignam, D L Wickerham, Richard G. Margolese, B Fisher, James N. Atkins, C Redmond, Neil Abramson, B S Aron
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 14(7)
PURPOSE To compare sequential methotrexate (M) and fluorouracil (F) (M-->F) with surgery (National Surgical Adjuvant Breast and Bowel Project [NSABP] B-13) and cyclophosphamide (C), M, and F with M-->F (NSABP B-19), in patients with estrogen receptor
Autor:
C K, Redmond, J P, Costantino
Publikováno v:
Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer. 140
From its inception the BCPT has been the focus of bitter sustained controversy. In spite of reassessments by numerous advisory groups that have deemed the trial to be scientifically, clinically and ethically sound, its opponents have continued their